The 1 analysts offering 12-month price forecasts for Midatech Pharma PLC have a median target of 1,574.74, with a high estimate of 1,574.74 and a low estimate of 1,574.74. The median estimate represents a +78,637.00% increase from the last price of 2.00.
The current consensus among 1 polled investment analysts is to Hold stock in Midatech Pharma PLC. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share --
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.